Net Loss per Share

12 Months Ended

Dec. 31, 2023

The following table sets forth the computation of basic and diluted net loss per share:


	Year Ended December 31, 2023		Year Ended December 31, 2022
Net loss	$	(614,928)	$	(78,782)

Basic weighted average number of shares of common stock outstanding	619,646,180		193,336,063
Diluted weighted average number of shares of common stock outstanding	619,646,180		193,336,063

Basic net loss per share	$	(0.99)	$	(0.41)
Diluted net loss per share	$	(0.99)	$	(0.41)

Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the diluted net loss by the weighted-average number of common shares outstanding for the period, including potentially dilutive common shares. Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods, as the inclusion of all potential common share equivalents outstanding would have been anti-dilutive.

Because the 2023 Rights Offering (as defined in Note 20) exercise price of $1.05 per share was less than the closing price of $1.82 per share on March 1, 2023, the expiration of the , the Company has retroactively adjusted earnings per share and weighted average number of shares outstanding for the bonus element for all periods presented.

The following potentially dilutive securities were excluded from the computation of the diluted net loss per share of common stock for the periods presented because their effect would have been anti-dilutive:


	2023	2022
Options to purchase common stock	54,209,289	19,476,359
Warrants	5,015,642	5,821,137
Shares expected to be purchased under employee stock purchase plan	155,163	229,475
	59,380,094	25,526,971

Stock options that are outstanding and contain performance-based or market-based vesting criteria for which the performance or market conditions have not been met are excluded from the presentation of common stock equivalents outstanding in the chart above. Refer to Note 21 for further information on market-based awards.